Evidence map›Paper›PMID 33917711›Full record

ArticleInternational journal of molecular sciences2021

MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System.

Sarah Teuber-Hanselmann, Karl Worm, Nicole Macha, Andreas Junker

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. OiScience · 2024
    Article
  6. Article
  7. Inflammation in Health and Disease: New Insights and Therapeutic Avenues.International journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarah Teuber-HanselmannInstitute of Neuropathology, University Hospital Essen, D-45147 Essen, Germany.
Karl WormInstitute of Pathology, University Hospital Essen, D-45147 Essen, Germany.
Nicole MachaInstitute of Neuropathology, University Hospital Essen, D-45147 Essen, Germany.
Andreas JunkerInstitute of Neuropathology, University Hospital Essen, D-45147 Essen, Germany.ORCID 0000-0002-8063-9765
Essen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantifying O

Indexed as

Disease SusceptibilityDNA MethylationAgedBiomarkersBiopsyCentral Nervous System DiseasesDNA Modification MethylasesDNA Repair EnzymesEpigenesis, GeneticFemaleGene Expression Regulation, NeoplasticHumansImmunohistochemistryMaleMiddle AgedMixed Function OxygenasesBiomarkersDNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanMixed Function OxygenasesProto-Oncogene ProteinsTET1 protein, humanTumor Suppressor Proteinscentral pontine and exptrapontine myelinolysisDNA-methylationMGMT promoter methylationmultiple sclerosisprogressive multifocal leucencephalopathy (PML)Wallerian degeneration

Identifiers

PMID33917711
PMCPMC8068191
OpenAlexW3143215483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.